GHK-CU
Also known as: Copper tripeptide-1, glycyl-L-histidyl-L-lysine copper(II) complex, GHK-Cu(II), copper peptide GHK, Gly-His-Lys-Cu²⁺, copper peptide
5 notable studies · 1 reference
TLDR
GHK-Cu is a copper-binding peptide studied for skin structure and tissue repair, with evidence of biological activity in laboratory and animal research but limited, mixed human findings that do not establish broad clinical benefits.
Research Supports
- Studied for effects on collagen production and connective-tissue/extracellular-matrix remodeling
- Investigated in experimental wound-healing and tissue-repair models
- Studied in topical cosmetic formulations for skin appearance, texture, and recovery after procedures
- Investigated for effects on matrix metalloproteinases involved in tissue remodeling
- Studied for copper-binding chemistry and how the peptide-copper complex is delivered to tissue
Observations Reported in Research
- Stimulated collagen synthesis in cultured fibroblasts without increasing cell number (Maquart et al., 1988)
- Increased accumulation of collagen and other connective-tissue components in a rat wound-chamber model (Maquart et al., 1993)
- A 13-person study after CO2 laser resurfacing found no significant objective difference in redness, wrinkles, or appearance, though a patient questionnaire favored GHK-Cu (Miller et al., 2006)
- A rat skin-flap irradiation study found no significant improvement in ischemia, blood-vessel measures, or VEGF expression (2013)
- Increased MMP-2 expression in fibroblast cultures, with copper ions alone reproducing the effect while GHK without copper did not (Siméon et al., 2000)
These are brief summaries of what the referenced research examined or reported — not conclusions about safety or effectiveness, and not medical advice. See Notable Studies and Sources & References below for the full context and citations.
At a Glance
Classification: Naturally occurring copper-binding tripeptide complex; metallopeptide; extracellular-matrix and tissue-remodeling research compound. GHK consists of three amino acids—glycine, histidine, and lysine—and can bind a copper(II) ion to form GHK-Cu.
GHK-CU is three amino acids, one copper ion, and a research history spanning decades. GHK-Cu is a naturally occurring complex formed when the small peptide GHK binds copper. Scientists have studied it for its effects on collagen production, connective tissue remodeling, and the biological processes involved in repairing damaged tissue. Much of the research focuses on skin. Laboratory experiments have found that GHK-Cu can influence the activity of fibroblasts—cells that help produce and maintain the structural material surrounding other cells. Animal studies have also investigated its effects on wound tissue. A smaller number of human studies have examined topical products containing GHK-Cu, primarily for cosmetic skin outcomes. Results have been mixed, and the studies are generally too small or limited to establish broad clinical benefits.
What Is GHK-CU?
GHK-Cu is a tiny peptide-copper complex with a surprisingly long research history. The peptide portion, GHK, is made of three amino acids: glycine (G), histidine (H), and lysine (K). GHK occurs naturally in the human body and can bind copper, forming the complex known as GHK-Cu. Copper is an essential trace element involved in many biological processes. GHK's ability to bind it has led researchers to investigate how this combination interacts with cells and tissues. One of the main areas of interest is the extracellular matrix—the network of collagen and other materials that gives tissues structure and support. In laboratory studies, GHK-Cu has influenced the production and remodeling of several extracellular-matrix components. Researchers have also investigated its effects on cells involved in wound repair. These observations helped establish GHK-Cu as a subject of skin and tissue-regeneration research. The compound has also appeared in cosmetic skin-care research, where topical formulations have been investigated for their effects on skin appearance and recovery after procedures. There is an important distinction between these areas of research: an effect observed in cultured cells does not automatically translate into visible skin changes, and results from a topical cosmetic product do not establish the safety or effectiveness of injecting GHK-Cu.
What Are Researchers Studying?
Skin structure and collagen production
Researchers are investigating how GHK-Cu affects fibroblasts and the production of collagen and other materials that give skin its structure. Laboratory studies have observed changes in collagen synthesis and extracellular-matrix components following exposure to GHK-Cu. Scientists are interested in whether these cellular effects translate into measurable changes in skin structure and appearance in people.
Wound healing and tissue repair
GHK-Cu has been studied in experimental wound models to understand its effects on the formation and remodeling of new tissue. Some animal studies have found increased collagen and other connective-tissue components in treated wounds, while other models have shown no clear advantage. Researchers are investigating which biological conditions, formulations, and delivery methods influence these outcomes.
Skin appearance and cosmetic formulations
Human studies have explored whether topical products containing GHK-Cu affect visible skin characteristics, including texture, wrinkles, and recovery after cosmetic procedures. The published findings are limited and mixed. Researchers continue to investigate whether changes observed in laboratory models translate into consistent, measurable cosmetic benefits.
Hair follicles and hair growth
Scientists have explored the effects of copper-binding peptides on hair-follicle biology and the cells that support hair growth. However, studies involving related peptides such as AHK-Cu should not be presented as direct evidence for GHK-Cu. Human research specifically examining GHK-Cu for hair-related cosmetic outcomes remains limited.
Copper binding and peptide delivery
Researchers are studying how GHK binds copper, how stable the resulting complex remains in different formulations, and how it reaches biological tissues. These questions matter because GHK alone, copper ions alone, and the copper-bound peptide may not produce identical effects. Understanding exactly which chemical form reaches a tissue is an important part of interpreting GHK-Cu research.
How Does It Work?
GHK-Cu appears to influence several processes involved in building, maintaining, and remodeling tissue. The story begins with its two components: a three-amino-acid peptide and a copper ion. GHK can bind copper(II), forming a complex that interacts with biological systems involved in connective-tissue maintenance and repair. One important area of research involves fibroblasts. These cells produce collagen and other materials that help form the extracellular matrix—the structural framework surrounding cells. In laboratory experiments, GHK-Cu has increased collagen synthesis in fibroblast cultures. Researchers have also observed changes in the production of glycosaminoglycans, molecules that contribute to the structure and organization of connective tissue. But tissue maintenance is not simply a matter of producing more collagen. Healthy tissue also requires remodeling: older or damaged material must be broken down and replaced as the surrounding structure changes. GHK-Cu has been shown to influence matrix metalloproteinases, enzymes involved in breaking down extracellular-matrix components, as well as proteins that regulate those enzymes. This suggests that its biological activity involves both the production and remodeling of connective tissue. Researchers have also investigated GHK-Cu's effects on other processes associated with tissue repair, including cellular responses to injury and the activity of molecules involved in inflammation and blood-vessel formation.
What Does the Research Show?
Human research
Evidence type: Limited human studies, primarily involving topical cosmetic formulations. Unlike some experimental peptides, GHK-Cu has been investigated in human participants. However, the clinical evidence is much smaller than the laboratory and animal literature. Several historical studies have explored topical copper-peptide products for cosmetic skin outcomes. Their findings have contributed to interest in GHK-Cu, but many are small, incompletely reported, or involve formulations whose precise active chemical composition was not fully characterized. One directly relevant controlled study was published in 2006. Researchers investigated whether skin-care products containing GHK-Cu improved recovery following carbon dioxide laser resurfacing around the mouth. Thirteen participants completed the study. The researchers found no statistically significant difference between treatment groups in the objective measures of redness resolution, wrinkles, or overall skin appearance. Participants using the GHK-Cu products did report greater improvement in overall skin quality on a questionnaire. This distinction matters: a favorable patient-reported result does not erase the absence of a measurable difference in the study's objective assessments. A 2026 study involving 18 participants also reported improvements in eyebrow hair measures with a topical formulation described as containing GHK-Cu. Its small size and limited characterization of the formulation mean the findings require further investigation. Overall, human research provides preliminary information about certain topical cosmetic applications, but it does not establish GHK-Cu as a clinically proven treatment for wound healing, hair loss, or systemic tissue regeneration.
Animal research
Evidence type: Preclinical animal studies, with results that vary by experimental model. Animal studies have investigated whether GHK-Cu influences the formation and repair of connective tissue. In a 1993 study, researchers used an experimental wound-chamber model in rats. They observed increases in collagen and other extracellular-matrix components in wound chambers exposed to GHK-Cu. These findings supported earlier laboratory observations that the peptide-copper complex can influence connective-tissue production. However, not every animal study has shown a benefit. A 2013 study investigated topical GHK-Cu gel in rats with surgically created skin flaps following irradiation. Researchers found no significant improvement in the measured outcomes, including flap ischemia, blood-vessel measures, and VEGF expression. Together, these studies illustrate an important point: a compound may influence tissue-related processes in one experimental model without producing a measurable improvement in another.
In-vitro research
Evidence type: Laboratory experiments involving isolated cells and biological materials. Some of the foundational GHK-Cu research comes from experiments involving fibroblasts, the cells responsible for producing much of the extracellular matrix. In a 1988 study, researchers found that GHK-Cu stimulated collagen synthesis in cultured fibroblasts without simply increasing the number of cells. A separate study published in 1992 found that GHK-Cu influenced the production of certain glycosaminoglycans in cultured human fibroblasts. Later research examined its effects on matrix metalloproteinase-2, an enzyme involved in extracellular-matrix remodeling. In that study, copper ions alone reproduced one observed effect, while the peptide without copper did not. This finding highlights why the distinction between GHK, GHK-Cu, and free copper matters when interpreting the research. These experiments provide insight into how GHK-Cu interacts with cellular processes involved in connective-tissue maintenance.
Notable Studies
Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+
in-vitroWhat researchers investigated: Whether GHK-Cu influences collagen production in cultured fibroblasts. What they found: GHK-Cu stimulated collagen synthesis without an accompanying increase in cell number. Why it matters: This study provides early experimental evidence that GHK-Cu can influence a cellular process central to connective-tissue maintenance.
Limitations: The experiments involved cultured cells, not human participants. Increased collagen synthesis in a laboratory does not automatically translate into improved skin appearance or wound healing.
View publication →In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds
animalWhat researchers investigated: Whether GHK-Cu affects connective-tissue accumulation in an experimental rat wound model. What they found: Wound chambers exposed to GHK-Cu showed increased accumulation of collagen and several other connective-tissue components. Why it matters: The study extended earlier cell-culture findings into a living animal model.
Limitations: This was an experimental wound-chamber model in rats. It does not establish that GHK-Cu accelerates ordinary wound closure or improves clinical outcomes in people.
View publication →Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin
humanWhat researchers investigated: Whether topical skin-care products containing GHK-Cu improved skin recovery and appearance following carbon dioxide laser resurfacing. What they found: Among the 13 participants who completed the study, objective assessments found no significant advantage for the GHK-Cu regimen in redness resolution, wrinkles, or overall skin appearance. A participant questionnaire did find a difference favoring the GHK-Cu group in perceived overall skin quality. Why it matters: This is a directly relevant human study that helps distinguish promising laboratory findings from demonstrated cosmetic outcomes.
Limitations: The study was small and evaluated a skin-care regimen rather than isolating every possible effect of GHK-Cu. Its findings cannot be generalized to other formulations or delivery methods.
View publication →Effects of topical copper tripeptide complex on wound healing in an irradiated rat model
animalWhat researchers investigated: Whether topical GHK-Cu gel improved outcomes in irradiated rat skin flaps. What they found: The study did not demonstrate significant improvements in the measured outcomes, including tissue ischemia, blood-vessel measures, or VEGF expression. Why it matters: It shows that the effects observed in earlier experiments do not necessarily translate into improved outcomes across different wound models.
Limitations: The experiment involved a specific rat model and topical formulation. A negative result in this setting does not settle every question about GHK-Cu's biological activity.
View publication →The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures
in-vitroWhat researchers investigated: Whether GHK-Cu influences an enzyme involved in the breakdown and remodeling of extracellular-matrix components. What they found: GHK-Cu increased MMP-2 expression in cultured fibroblasts and influenced proteins that regulate matrix-degrading enzymes. Copper ions alone reproduced the MMP-2 effect, while GHK without copper did not. Why it matters: This study adds nuance to the idea of tissue repair: GHK-Cu may influence the remodeling of connective tissue, not simply the production of more collagen.
Limitations: The study examined isolated cells and molecular markers. It did not measure clinical wound healing or cosmetic outcomes.
View publication →What We Still Don't Know
GHK-Cu has a substantial history of experimental research, but several questions remain open. How much do laboratory findings translate into visible changes in human skin? Researchers have observed effects on collagen and other extracellular-matrix components in cell cultures. Human studies have not yet established how consistently these changes translate into meaningful cosmetic or clinical outcomes. Does GHK-Cu improve wound healing in humans? Animal studies have produced findings that vary across experimental models. Larger, well-controlled human studies are needed to establish whether specific GHK-Cu formulations improve wound-healing outcomes. Which chemical form is responsible for each observed effect? GHK, copper-bound GHK, and free copper are not identical. Some studies do not fully characterize the chemical form present in the tested formulation or reaching the target tissue. How much does formulation matter? A topical cosmetic product, a laboratory solution, and an engineered delivery system may behave differently. Findings from one preparation cannot automatically be applied to another. What is the safety profile of injectable GHK-Cu? The limited human topical research does not establish the safety of injecting GHK-Cu. Questions about formulation quality, immune reactions, copper exposure, and longer-term effects require separate investigation. Can GHK-Cu meaningfully affect human hair growth? Hair-follicle research involving related copper peptides is sometimes attributed to GHK-Cu, even when a different compound was studied. Human findings specific to GHK-Cu remain limited. What happens with long-term exposure? The available studies do not establish long-term safety or clinical outcomes across different formulations and routes of exposure.
Recent publications
Latest titles from PubMed, not reviewed by Aminodex. Not an endorsement. See all on PubMed ↗
Take the GHK-CU research with you.
Get the Aminodex GHK-CU Brief—a concise summary of the research, notable studies, evidence types, limitations, and references.
One-time email. We do not add you to any mailing list.
Sources & References
Supplier Listings
Disclosure: The owner of Aminodex operates the supplier(s) marked below. These listings are promotion for businesses we own, not independent recommendations. Read our disclosures.